Petra Reinke

Title: Petra Reinke: Innovator in Immunology

Introduction

Petra Reinke is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of immunology, particularly in the development of targeted therapies for various diseases. With a total of 8 patents to her name, her work has the potential to impact the treatment of cardiac insufficiency and other conditions.

Latest Patents

One of her latest patents involves B-lymphocyte targeting agents for use in a method for the treatment of diseases. This invention focuses on a B-lymphocyte targeting agent that can be utilized in diagnosing and treating cardiac insufficiency. Additionally, she has developed a composition that includes such targeting agents and methods to determine if a patient with cardiac insufficiency is suitable for this treatment. Another notable patent pertains to antigen-specific central-memory T cell preparations that have a high CD4+ fraction. This invention outlines a method for generating T cell preparations specific to at least one target antigen, which includes expanding lymphoid cells in vitro and isolating cells that secrete interferon gamma.

Career Highlights

Throughout her career, Petra has worked with esteemed institutions, including Charité - Universitätsmedizin Berlin. Her innovative research has positioned her as a key figure in the field of immunology, contributing to advancements that could lead to more effective treatments for patients.

Collaborations

Petra has collaborated with notable colleagues such as Hans-Dieter Volk and Florian Kern. Their combined expertise has further enhanced the impact of her research and inventions.

Conclusion

Petra Reinke's contributions to immunology through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in medical treatments, particularly in the realm of targeted therapies.